Lois Commodore

2.1k citations
7 papers · 1.8k · 1 hit paper · h-index 7

Impact in

  • Hematology top 1%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 2%
    • Chronic Lymphocytic Leukemia Research

Papers in

Lois Commodore

7 papers receiving 1.7k citations

Lois Commodore's Hit Papers

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance 2009 · 1.0k citations
1.0k0+5+11Years since publication2505007501000

Peers

Lois Commodore
Comparison fields: 5 of 68
  • Hematology 1.0k
  • Genetics 609
  • Rheumatology 318
  • Oncology 312
  • Organic Chemistry 267
Replace Jeffrey A. Keats with:
Jeffrey A. Keats United States
Mathew Thomas United States
Mei-Li Wen United States
Lauren T. Adrian United States
Elizabeth Hall–Meyers United States
Laurie Catley United States
Ines Kaupe Austria
K. Gary J. Vanasse United States
Jeff Keats United States
Lois Commodore relative to Jeffrey A. Keats United States Jeffrey A. Keats's profile →
Citations per field
00.5×1.5×
Jeffrey A. Keats · 1×
Citations per year

Countries citing papers authored by Lois Commodore

Since Specialization
Citations

This map shows the geographic impact of Lois Commodore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois Commodore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois Commodore more than expected).

Fields of papers citing papers by Lois Commodore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois Commodore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois Commodore. The network helps show where Lois Commodore may publish in the future.

Co-authors

The 17 scholars most cited alongside Lois Commodore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lois Commodore Line = papers co-authored together Lois Commodore links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Hit paper breakdown →
20091045
2 2010323
3 2010241
4 201374
5 200333
6 200926
7 201116

About Lois Commodore

Lois Commodore is a scholar working on Hematology, Rheumatology, Genetics, Cancer Research and Molecular Biology, having authored 7 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Chronic Lymphocytic Leukemia Research (2 papers), S100 Proteins and Annexins (1 paper), Protein Structure and Dynamics (1 paper), Protein Degradation and Inhibitors (1 paper), Quinazolinone synthesis and applications (1 paper) and Lipid Membrane Structure and Behavior (1 paper). The work is most often cited by research in Hematology (1.0k citations), Genetics (609 citations), Rheumatology (318 citations), Oncology (312 citations) and Organic Chemistry (267 citations). Lois Commodore has collaborated with scholars based in United States. Frequent co-authors include Wei‐Sheng Huang, Yihan Wang, Tim Clackson, Tianjun Zhou, William C. Shakespeare, Xiaotian Zhu, David C. Dalgarno, Victor M. Rivera, Jeff Keats and Qihong Xu. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Cancer Cell, Journal of Biological Chemistry and Chemical Biology & Drug Design.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact